Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 7Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Hodgkin Disease 6Urinary Bladder Neoplasms 4Melanoma 2Lymphoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Seminoma 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1Childhood Solid Tumor 1Carcinoma, Embryonal 1Bladder Adenocarcinoma 1

Interventions

pembrolizumab 51Ipilimumab 50Cyclophosphamide 43Nivolumab 41aldesleukin 30Interleukin-2 23Vemurafenib 20fludarabine 19Temozolomide 18fludarabine phosphate 15dabrafenib 15trametinib 12spartalizumab 10Radiotherapy 10Radiosurgery 10Dacarbazine 10CTLA-4 Antigen 10cobimetinib 9binimetinib 9poly ICLC 7encorafenib 7Paclitaxel 7atezolizumab 6Introns 6Biopsy 6montanide ISA 51 5Carboplatin 5epacadostat 4MART-1 Antigen 4Interferon alpha-2 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Melanoma × Vinblastine × Clear all
NCT00505635 2020-09-24

Biochemotherapy With Temozolomide for Metastatic Melanoma

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 5 charts
Dermatologic

Melanoma

NCT01542255 2019-01-15

Metronomic Therapy in Patients With Metastatic Melanoma

Dartmouth-Hitchcock Medical Center

Phase 2 Terminated
7 enrolled 4 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡